Heart Valve Repair and Replacement Devices Market - Global Outlook and Forecast 2018-2023 - ResearchAndMarkets.com

September 4, 2018

DUBLIN--(BUSINESS WIRE)--Sep 4, 2018--The “Heart Valve Repair and Replacement Devices Market - Global Outlook and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering.

The global heart valve repair and replacement devices market is expected to generate revenues of more than $12 billion by 2023, growing at an impressive CAGR of around 17% during 2017-2023.

The global heart valve repair and replacement devices market is driven by growing technological advancements, new product approvals, a growing elderly population, and improvements in reimbursement policies.

The government organizations and leading manufacturers involved in spreading awareness, education, and support about various types of cardiac diseases will have a positive impact on the global market. Top vendors in the transcatheter space, startups, and small medtech investigational companies are actively engaged in developing next-generation medical devices creating lucrative opportunities in the market.

The increasing adoption of transcatheter and other MI heart valve procedures will transform the global market. The market research report provides in-depth market analysis and segmental analysis of the global heart valve repair and replacement devices market by product, surgery type, end-user, and geography.

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Report Coverage

5 Report Assumptions & Caveats

6 Market at a Glance

7 Introduction

8 Market Dynamics

9 Global Heart Valve Repair and Replacement Devices Market

10 Market by Product Types

11 Global Heart Valve Repair Devices Market

12 Global Heart Valve Replacement Devices Market

13 Market by Surgery Type

14 Market by End-User

15 Market By Geography

16 North America

17 Europe


19 Latin America

20 Middle-East and Africa

21 Competitive Landscape

22 Key Company Profiles

23 Other Prominent Vendors

24 Investigational Companies

25 Report Summary

Companies Mentioned

Valcare Medical MVRx Mardil Medical Ancora Heart TORAY INDUSTRIES NeoChord Balton Cephea Valve Technologies Millipede JenaValve Technology Colibri Heart Valve VENUS MEDTECH Mitralign Micro Interventional Devices Lepu Medical Technology CryoLife Cardiac Dimensions BioStable Science & Engineering LivaNova Edwards Lifesciences Abbott BD Boston Scientific Medtronic

For more information about this report visit https://www.researchandmarkets.com/research/6hlgdc/heart_valve?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180904005418/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/04/2018 07:10 AM/DISC: 09/04/2018 07:10 AM


Update hourly